Latest Market News
The FSMA once again warns the people of Belgium against recovery room fraud. In recent months, the FSMA has observed an increase in the number of reports by consumers about what are known as ‘recovery rooms’. Recovery room fraud is a practice whereby fraudsters offer to help victims of investment fraud to obtain compensation for […]
During the last weeks, the FSMA continued to receive complaints from consumers concerning new fraudulent online trading platforms that are operating in the Belgian market. The approach remains the same. These trading platforms try to arouse consumers’ curiosity by placing scam ads on social media such as Facebook. In these fake ads, a well-known person […]
The Financial Services and Markets Authority (FSMA) warns the public against the activities of Bitcoin-Evolution and Bitcoin-Revolution, entities that offers investments without complying with Belgian financial legislation. Bitcoin-Evolution and Bitcoin-Revolution are not allowed to provide banking and/or investment services in or from Belgium. Those entities approach Belgian consumers through publications on social media and fake […]
Fraudsters are not hesitating to exploit the current COVID-19 situation. Beware, since the current climate is particularly propitious for these swindlers to create more victims. Most of the time, they contact their victims by using phishing techniques disseminated via different channels: email, social media or unsolicited phone calls. The FSMA was informed that malicious persons […]
Bitcoin (BTC) held above $41,000 into the weekend after a late surge Friday took the largest cryptocurrency to two-week highs. BTC/USD 1-day candle chart (Bitstamp). Source: TradingView “The only good bear is a dead bear” Data from Cointelegraph Markets Pro and TradingView showed BTC/USD maintaining newly re-won ground Saturday, with the pair’s correlation to stock makets […]
Regeneron Pharmaceuticals Inc. shares REGN, +0.37% rose 1.8% in premarket trade Friday, after the company doubled its fourth-quarter revenue as sales of its COVID-19 antibody treatment came to $2.3 billion. The company posted net income of $2.229 billion, or $19.69 a share, for the quarter, up 94% from $1.149 billion, or $10.24 a share, in […]